Avodart (dutasteride) May Prevent Prostate Cancer
March 9th, 2010 by Nina Thompson, ARNP
Avodart (dutasteride) may both prevent prostate cancer and improve the predictive power of the blood test, PSA, according to researchers from the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia. In their recent study of men with benign prostatic hyperplasia (BPH), the medication was associated with a 40% lower incidence of prostate cancer diagnosis than the BPH drug tamsulosin (Flomax) [...]
Bookmark this page
E-mail this story
Print this post
